Literature DB >> 5048649

Interaction in the cerebral metabolism of the biogenic amines. Effect of phenelzine on this interaction.

A T Moir, C M Yates.   

Abstract

1. Chronic administration of phenelzine to dogs caused the concentrations of homovanillic acid (HVA) in c.s.f. from both the lateral ventricle and cisterna magna to fall to new low levels at which they were maintained.2. After 10-12 days treatment with phenelzine the caudate nucleus had elevated concentrations of dopamine and 3-methoxytyramine and lowered concentrations of 3,4-dihydroxyphenylacetic acid and HVA.3. Intravenous administration of tryptophan to dogs pretreated with phenelzine caused in c.s.f. an increase in the concentrations of HVA and in the caudate nucleus a decrease in dopamine concentration and an increase in the concentrations of its metabolites, 3-methoxytyramine, 3,4-dihydroxyphenylacetic acid and HVA.4. A model is proposed for the cerebral metabolism of dopamine and some of the points at which tryptophan and its metabolites may interact with dopamine metabolism are discussed.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5048649      PMCID: PMC1666137          DOI: 10.1111/j.1476-5381.1972.tb08081.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Modification of chronic manganese poisoning. Treatment with L-dopa or 5-OH tryptophane.

Authors:  I Mena; J Court; S Fuenzalida; P S Papavasiliou; G C Cotzias
Journal:  N Engl J Med       Date:  1970-01-01       Impact factor: 91.245

2.  Homovanillic acid, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindol-3-ylacetic acid in serial samples of cerebrospinal fluid from the lateral ventricle of the dog.

Authors:  G W Ashcroft; T B Crawford; R C Dow; H C Guldberg
Journal:  Br J Pharmacol Chemother       Date:  1968-07

3.  The effects of precursor loading in the cerebral metabolism of 5-hydroxyindoles.

Authors:  A T Moir; D Eccleston
Journal:  J Neurochem       Date:  1968-10       Impact factor: 5.372

4.  Species differences in subcellular distribution of choline acetylase in the CNS. A study of choline acetylase, acetylcholinesterase, 5-hydroxytryptophan decarboxylase, and monoamine oxidase in four species.

Authors:  R E McCaman; G Rodríguez de Lores; E De Robertis
Journal:  J Neurochem       Date:  1965-11       Impact factor: 5.372

5.  The rate of norepinephrine synthesis measured in vivo during short intervals; influence of adrenergic nerve impulse activity.

Authors:  G C Sedvall; V K Weise; I J Kopin
Journal:  J Pharmacol Exp Ther       Date:  1968-02       Impact factor: 4.030

6.  Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration.

Authors:  N H Neff; E Costa
Journal:  J Pharmacol Exp Ther       Date:  1968-03       Impact factor: 4.030

7.  Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.

Authors:  H C Guldberg; G W Ashcroft; T B Crawford
Journal:  Life Sci       Date:  1966-09       Impact factor: 5.037

8.  The active transport of 5-hydroxyindol-3-ylacetic acid and 3-methoxy-4-hydroxyphenylacetic acid from a recirculatory perfusion system of the cerebral ventricles of the unanaesthetized dog.

Authors:  G W Ashcroft; R C Dow; A T Moir
Journal:  J Physiol       Date:  1968-12       Impact factor: 5.182

9.  Changes in the metabolism of 3,4-dihydroxyphenylethylamine (dopamine) in the striatum of the mouse induced by drugs.

Authors:  D F Sharman
Journal:  Br J Pharmacol Chemother       Date:  1966-11

10.  A method for the estimation of the catecholamines and their metabolites in brain tissue.

Authors:  T B Crawford; C M Yates
Journal:  Br J Pharmacol       Date:  1970-01       Impact factor: 8.739

View more
  1 in total

1.  Involvement of biogenic amines in drug-induced aggressive pecking in chicks.

Authors:  B Hine; M B Wallach; S Gershon
Journal:  Psychopharmacologia       Date:  1975-09-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.